Mark William Lowdell

Insider Reports History

Location
Beaumont
Signature
/s/ Mark William Lowdell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark William Lowdell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inmune Bio, Inc. Chief Scientific Officer Option (right to buy) 600K 01 Dec 2025 Direct
Inmune Bio, Inc. Chief Scientific Officer Stock Option (right to buy) 100K 18 Nov 2025 Direct

Insider Reports Filed by Mark William Lowdell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INMB Inmune Bio, Inc. 01 Dec 2025 1 $0 4 Chief Scientific Officer 02 Dec 2025, 16:43
INMB Inmune Bio, Inc. 18 Nov 2025 10 $0 4 Chief Scientific Officer 18 Nov 2025, 17:29
INMB Inmune Bio, Inc. 05 Dec 2024 1 $0 4 Chief Scientific Officer, 10%+ Owner 09 Dec 2024, 16:00
INMB Inmune Bio, Inc. 14 May 2024 1 $0 4 Chief Scientific Officer, 10%+ Owner 16 May 2024, 16:08
INMB Inmune Bio, Inc. 19 Apr 2024 2 $122K 4/A Chief Scientific Officer, 10%+ Owner 24 Apr 2024, 14:08
INMB Inmune Bio, Inc. 19 Apr 2024 2 $122K 4 Chief Scientific Officer, 10%+ Owner 23 Apr 2024, 17:54
INMB Inmune Bio, Inc. 21 Mar 2022 2 $199K 4 Chief Scientific Officer, 10%+ Owner 23 Mar 2022, 16:35
INMB Inmune Bio, Inc. 03 Nov 2021 1 -$14K 4 Chief Scientific Officer, 10%+ Owner 04 Nov 2021, 16:00
INMB Inmune Bio, Inc. 27 Oct 2021 1 -$47.1K 4 Chief Scientific Officer, 10%+ Owner 29 Oct 2021, 16:03
INMB Inmune Bio, Inc. 22 Oct 2021 1 -$8K 4 Chief Scientific Officer, 10%+ Owner 26 Oct 2021, 16:31
INMB Inmune Bio, Inc. 07 Jul 2021 2 -$605K 4 Chief Scientific Officer 09 Jul 2021, 16:06